Gastrointestinal Cancer News

In the 36 months prior to diagnosis of pancreatic ductal adenocarcinoma, researchers observed “predominant changes” in patients’ body composition and biochemical markers, which may serve as potential biomarkers for early cancer detection.

Timing of adjuvant chemotherapy initiation may affect outcomes among patients who undergo surgery for colorectal cancer, according to data published in JAMA Surgery.

Cancer survivors with the lowest socioeconomic status appeared twice as likely to die of CVD than those with the highest household incomes, according to a study published in European Heart Journal – Quality of Care and Clinical Outcomes.

Individuals who smoke tobacco using a waterpipe had a higher risk for death from multiple cancer types compared with those who never smoked, according to data from an ongoing cohort study published in JAMA Oncology.

CHICAGO — Most individuals with cancer who used an AI-based nutritional platform reported the application helped them regulate their diets and improved their quality of life, according to study results presented at ASCO Annual Meeting.

AI has already made its mark in gastroenterology as a tool for detecting gastrointestinal lesions, adenomas and inflammatory bowel disease. However, its next phase of evolution might seem the most unlikely: Aiding colonoscopy preparation.

Compared with non-Hispanic white individuals, patients from racial and ethnic minority groups experienced similar clinical benefits when participating in phase 1 trials for advanced cancers, data published in JAMA Network Open showed.

About 40% of cancer cases and nearly half of cancer deaths among U.S. adults aged 30 years or older can be attributable to modifiable risk factors, according to a study led by American Cancer Society researchers.

Although adherence to standardized reporting guidelines ranged from 82.4% to 92.2% in published trials of colorectal cancer screening, researchers found that reporting of trial registration and informed consent materials could be improved.

A continuous risk score accurately predicted waitlist dropout and post-liver transplantation outcomes in patients with hepatocellular carcinoma, even over the course of several UNOS policy changes, researchers reported.